This was statistically only partially explained by prevention of critical illness polyneuropathy/myopathy. Conclusion: In a subset of medical patients in the intensive care unit for at least 7 days, enrolled in a randomized controlled trial of intensive insulin therapy, those assigned to intensive insulin therapy had a reduced incidence of critical illness polyneuropathy/myopathy and were treated with prolonged mechanical ventilation less frequently.
Intensive insulin therapy prevents critical illness polyneuropathy in medical ICU patients and is associated with reduced requirements for prolonged mechanical ventilation.
than seven times (9) . In these patients, a coexistent primary muscle disease is often present, termed "critical illness myopathy" (CIM) (5, 8, 10) .
Several risk factors for this disease have been identified, such as the use of corticosteroids (11) , neuromuscular blocking agents (9, (12) (13) (14) , vasopressors (15, 16) , or aminoglycosides (17) (18) (19) , organ failure (20) , and parenteral nutrition (9) , renal replacement therapy (9) , and duration of intensive care unit (ICU) stay (15) . Until recently, the only possible way to affect the incidence of CIP or CIM was to reduce the risk factors (8) . However, strict glycemic control in a surgical ICU substantially reduced the incidence of CIP in the subset of patients who stayed in the ICU for at least 7 days. This was accompanied by a lower incidence of prolonged mechanical ventilation (15) . In the current study, we examine the effect of the same therapeutic intervention in a medical ICU population, which, by the nature of the diseases for which ICU admission is required, has a greater exposure to the known risk factors for CIP and CIM as compared with surgical patients.
Some of the results in this article have been presented as an abstract (21) .
METHODS
This study is a prospectively planned subanalysis of a randomized controlled trial (n ϭ 1,200) of medical ICU patients allocated to either intensive or conventional insulin therapy ( Figure 1 ). Intensive insulin therapy (IIT) was aimed at blood glucose levels of between 80 and 110 mg/dl. The conventional insulin therapy (CIT) approach required insulin only when blood glucose rose above 215 mg/dl and tapering or stopping insulin when blood glucose fell below 180 mg/dl. Details of the entire patient population have been described elsewhere (22) . Details on measurement of blood glucose, ventilation, weaning, and feeding strategies are given in the online supplement. Here, we assessed the impact of IIT on CIP and/or CIM (CIP/CIM), and duration of mechanical ventilation, and compared the incidence of CIP/CIM and its risk factors between medical and surgical patients in the ICU for at least 7 days.
Diagnosis of CIP/CIM
The diagnosis of CIP was made using electroneuromyography (ENMG) (4, 23, 24) . Differentiation between CIP and CIM based on electrophysiologic data without muscle biopsy is only possible in cooperative patients or in those with strictly sensory CIP (4, 5, 8, 24) . At this time, there is no evidence that differentiating between neuropathy and myopathy has any impact on patients' prognosis (4, 24) . Therefore, we will use the term "critical illness polyneuropathy/myopathy" (CIP/CIM) in this study. Further details on the diagnosis of CIP/CIM are given in the online supplement.
Statistics
Data were analyzed using Statview 5.0 (SAS Institute, Inc., Cary, NC) software. Baseline and outcome variables were depicted as means Ϯ SD or medians (interquartile ranges). Results were compared using Student's t test, chi-square test, or Mann-Whitney U test when appropriate.
Time to weaning from mechanical ventilatory support was evaluated using cumulative hazard estimates and proportional hazard regression analysis, corrected for baseline risk factors and censoring for early deaths. The definition of prolonged mechanical ventilation was 14 days or more, which is the same as in our surgical study (15) . Time to the first positive ENMG was also evaluated using cumulative hazard estimates and Cox regression analysis.
A univariate analysis of outcome was performed for the development of CIP/CIM and prolonged mechanical ventilation, evaluating the effect of treatment allocation, baseline risk factors, and known risk factors occurring during ICU stay. These risk factors are mentioned in the online supplement.
In addition to these univariate analyses of outcome, the effect of treatment allocation on the occurrence of CIP/CIM and prolonged mechanical ventilation was assessed using multivariate logistic regression analysis, correcting for those risk factors that showed at least a trend toward significance (p р 0.1) in the univariate analysis. To examine whether affecting the incidence of CIP/CIM could explain the effect of IIT on prolonged mechanical ventilation, presence or absence of CIP/CIM was entered into the multivariate logistic regression analysis for prolonged mechanical ventilation. Finally, to assess which component of IIT (blood glucose control or insulin dose) best explained its possible impact on CIP/CIM and prolonged mechanical ventilation, mean blood glucose level and insulin dose were added to the models. Parameters were checked for linearity, and nonlinear parameters were entered into the model as nominal variables.
RESULTS

Patient Characteristics
A total of 443 of 1,200 patients were in the ICU for at least 7 days (Figure 1 ). ENMG data were unavailable for 23 of the 443 patients either due to technical problems or to preexisting neuromuscular disease. Of the remaining 420 patients, 212 were in the CIT group, and 208 in the IIT group. Demographic data and baseline and outcome characteristics of these patients are shown in Table 1 . The CIT and IIT groups were comparable on ICU admission, apart from a slightly younger age, and a slightly lower baseline creatinine level, in the intensive group. Censoring patients in the ICU for fewer than 7 days did not lead to selection bias because outcome in the censored group was not affected by IIT (Table 1) .
Glycemic Control
As per protocol, median a.m. blood glucose levels were 159 (interquartile range [IQR], 139-172) mg/dl in the conventional Definition of abbreviations: APACHE ϭ Acute Physiology and Chronic Health Evaluation; BMI ϭ body mass index; CIT ϭ conventional insulin therapy; CRP ϭ C-reactive protein; ICU ϭ intensive care unit; IIT ϭ intensive insulin therapy; IQR ϭ interquartile range.
CHARACTERISTICS OF THE INTENTION-TO-TREAT GROUP, PATIENTS SCREENED FOR CRITICAL ILLNESS POLYNEUROPATHY (UNCENSORED), AND THOSE EXCLUDED (CENSORED)
Boldface type indicates statistically significant results. * Data are presented as mean and SD if normally distributed. These groups were compared using Student's t test. For nonnormally distributed variables, the MannWhitney U test was used. For contingent data, chi-square was used.
group and 102 (IQR, 97-115) mg/dl in the intensive group (p Ͻ 0.0001). These levels were achieved with 22 (5-43) units insulin per day in the conventional group and 71 (52-101) units in the intensive group (p Ͻ 0.0001).
Neuromuscular Outcome
An ENMG diagnosis of CIP/CIM was significantly more frequent in the CIT group (107/212 [50.5%]) than in the IIT group (81/208 [38.9%]) (p ϭ 0.02 with the chi-square test) ( Figure 2) . Furthermore, the cumulative risk of CIP/CIM over time was significantly reduced by IIT ( Figure 3 , upper panel). As shown in Table 2 , there was no difference in the incidence of known risk factors for CIP/CIM between the IIT and CIT groups, except for the maximal sequential organ failure assessment (SOFA) score during ICU stay (p ϭ 0.02) and ICU stay itself (p ϭ 0.02), which were significantly lower in the IIT group. Multivariate logistic regression analysis, correcting for those risk factors that showed at least a trend toward significance in the univariate analysis (Table  3 ), demonstrated that treatment allocation to IIT remained an independent protective factor for ENMG diagnosis of CIP/CIM (p ϭ 0.02; odds ratio [OR], 0.61 [95% confidence interval (CI), 0.43-0.92]) after correction for baseline severity of illness and for the known risk factors occurring during ICU stay (Table 4) .
Prolonged infusion of neuromuscular blocking agents was an independent risk factor for the occurrence of at least one positive ENMG (p ϭ 0.02; OR, 2.01 When entering mean daily blood glucose level and mean daily insulin dose into the model, neither of these could independently explain the prevention of CIP/CIM with IIT (IIT: p ϭ 0.08; OR, 0.50 [0.23-1.07]; mean daily insulin dose: p ϭ 0.8; OR, 1.00 [1.00-1.00]; mean daily glucose level: p ϭ 0.5; OR, 1.00 [0.99-1.00]).
Prolonged Mechanical Ventilation
The cumulative chance of successful weaning from mechanical ventilation was increased by IIT, as shown by the cumulative hazard plots in Figure 3 , lower panel (p ϭ 0.01). The number of days on the ventilator was reduced from a median of 14 (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) to 12 (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) days (p ϭ 0.04).
IIT significantly reduced the incidence of treatment with prolonged mechanical ventilation from 99 of 212 patients (46.7%) in the CIT group to 72 of 208 patients (34.6%) in the IIT group (p ϭ 0.01). IIT remained an independent protective factor against treatment with prolonged mechanical ventilation (p ϭ 0.01; OR, 0.56 [0.36-0.87]) in the multivariate logistic regression model. Independent risk factors were as follows: an on-admission diagnostic category of "respiratory" (p ϭ 0.03; OR, 4.17 [1.12-15 .50]) as compared with "cardiovascular," number of days of 
TABLE 2. INCIDENCE OF KNOWN RISK FACTORS DURING ICU STAY FOR CIP/CIM IN THE INTENTION-TO-TREAT GROUP, PATIENTS SCREENED FOR CIP/CIM (UNCENSORED), AND THOSE EXCLUDED FOR ANALYSIS (CENSORED)
IQR) 0 (0-0) 0 (0-0) 0.7 0 (0-0) 0 (0-0) 0.7 0 (0-0) 0 (0-0) 0.8
Comparison between Medical and Surgical Patients in the ICU for at Least 7 Days
The incidence of CIP/CIM in the conventional insulin group (50.5%) was comparable to that in the surgical ICU population Definition of abbreviations: ALT ϭ alanine transaminase; APACHE ϭ Acute Physiology and Chronic Health Evaluation; CIM ϭ critical illness myopathy; CIT ϭ conventional insulin therapy; CRP ϭ C-reactive protein; ENMG ϭ electroneuromyography; ICU ϭ intensive care unit; IIT ϭ intensive insulin therapy; IQR ϭ interquartile range; MV ϭ mechanical ventilation; SOFA ϭ sequential organ failure assessment; TISS ϭ therapeutic intervention scoring system.
Boldface type indicates statistically significant results. * Risk factors occurring during ICU stay were calculated for each patient up to the point of diagnosis of presence or absence of CIP/CIM (first positive or last negative ENMG).
† Risk factors occurring during ICU stay were calculated for the first 14 days. ‡ This is the time frame during which the risk factors occurring during ICU stay were examined. Time to diagnosis was defined as the time to first positive ENMG for patients with CIP/CIM or time to last negative ENMG for patients without CIP/CIM. Definition of abbreviations: APACHE ϭ Acute Physiology and Chronic Health Evaluation; CIM ϭ critical illness myopathy; CIT ϭ conventional insulin therapy; ENMG ϭ electroneuromyography; IIT ϭ intensive insulin therapy; IQR ϭ interquartile range; MV ϭ mechanical ventilation; NMBAs ϭ neuromuscular blocking agents; SOFA ϭ sequential organ failure assessment; TISS ϭ therapeutic intervention scoring system.
TABLE 4. MULTIVARIATE LOGISTIC REGRESSION ANALYSIS FOR THE RISK FOR DEVELOPMENT OF CIP/CIM AND PROLONGED MECHANICAL VENTILATION
† Risk factors occurring during ICU stay were calculated for the first 14 days. ‡ Colinearity with APACHE II. § Colinearity with norepinephrine and dialysis. || Colinearity with norepinephrine: eliminating these variables does not change the conclusion of the multivariate logistic regression analysis.
(49%) (15) . The absolute reduction by IIT of the risk for CIP/ CIM was even greater in the surgical population (Ϫ24%) than in the medical population (Ϫ11.6%). However, the incidence of some classical risk factors for CIP/CIM, such as use of neuromuscular blocking agents, corticosteroids, and dialysis, was clearly higher in the medical population (Table 5) (15) .
DISCUSSION CIP/CIM
CIP/CIM is an important and frequent complication in critically ill patients and associated with considerable morbidity and increased mortality. In our surgical ICU population, the occurrence of CIP/CIM was significantly reduced by IIT, which was aimed at blood glucose levels between 80 and 110 mg/dl (15) . In the current study, we demonstrated that IIT, in a medical population who stayed in the ICU for at least 7 days, significantly reduced the incidence of CIP/CIM.
We noticed a comparable incidence of CIP/CIM in the conventional treatment groups of both the surgical and medical long-stay population in the presence of substantially different risk factor pressure. This suggests that these risk factors per se might be less important than the sustained presence of metabolic disturbances over time in the ICU, which can be at least partially prevented by IIT. Indeed, the protective effect of IIT on the occurrence of CIP/CIM in the medical ICU population confirms the beneficial effect, even in a population that is theoretically considered to be at much higher risk.
The mechanisms underlying these observations remain unclear. The peripheral effects of chronic hyperglycemia on the nervous system in diabetes are well known (25) . As we have hypothesized before, in critically ill patients the peripheral nervous system might be at increased risk for the accelerated development of damage by hyperglycemia due to passive uptake of glucose and increased generation and/or a deficient scavenging system for reactive oxygen species (26) . We hypothesized that avoiding hyperglycemia may exert a similar protective effect on neural mitochondrial structure and function (15) , as in hepatocytes (27) . Maintaining normoglycemia also reduces organ damage by endothelial protection through a diminished release of nitric oxide (28) . As we have published before, insulin therapy itself, however, may also contribute to beneficial effects of the intensive therapy regimen due to endothelial protection, reduced inflammation, and improvement of dyslipidemia (26, 28, 29) . However, in this study, multivariate logistic regression analysis showed that neither hyperglycemia nor insulin dose was exclusively or independently responsible for the effect of IIT on CIP/ CIM.
Interestingly, we found that corticosteroids appeared to exert a protective effect on the occurrence of CIP/CIM. This confirms our previous observation in the surgical population (15) . Almost three-quarters of our patients received glucocorticoids. This figure may seem high, but the population studied was not an average ICU population but consisted of the sickest patients who were in ICU for at least 7 days. Data in the literature on the impact of corticosteroids on neuromuscular function have been controversial. Different reports have described an increase in CIM (12, 14) and CIP (13) in patients treated with a combination of corticosteroids and neuromuscular blocking agents. Most reports regarding the effect of steroids alone on CIP (9) or CIM (12, 30, 31) and CIP/CIM (20, 32) did not find such a correlation. In two reports, however, corticosteroids were found to be an important risk factor for the development of neuromuscular disorders in patients in the ICU (11, 33) . Our results, however, indicated that corticosteroids, which are known to cause hyperglycemia and insulin resistance (34), may not exert deleterious effects on CIP/CIM when blood glucose levels are kept normal with insulin, and might even be protective. Whether antiinflammatory properties of glucocorticoids might also exert a beneficial effect on the neuromuscular system and explain this finding needs further investigation.
Our results also confirm the increased risk for CIP/CIM due to prolonged infusion of neuromuscular blocking agents. An unusual finding, however, was the protective effect of aging on the development of CIP/CIM. We do not have an explanation for this.
Prolonged Mechanical Ventilation
We also examined the effect of IIT on the incidence of prolonged mechanical ventilation. IIT clearly reduced the incidence of prolonged mechanical ventilation. Multivariate regression analysis showed that, after correction for baseline parameters for severity of illness and risk factors occurring during ICU stay, IIT itself significantly and independently reduced the risk for prolonged mechanical ventilation. This effect appeared not to be entirely explained by the reduction in the incidence of CIP/CIM.
Multivariate logistic regression analysis showed, however, that the effect of IIT in reducing the incidence of prolonged mechanical ventilation, independent of the reduction in CIP/CIM, was entirely attributable to the daily insulin dose. Insulin is known to have an anabolic effect on the skeletal muscle (35) . Further research needs to clarify if this mechanism can explain our results.
Interestingly, the number of days of treatment with glucocorticoids clearly increases the risk for prolonged mechanical ventilation. Glucocorticoids are indeed known to have catabolic effects on the skeletal muscle (36) . We did notice that the diagnosis of CIP/CIM was made, and therefore risk factors were analyzed, over a median duration of 8 days. Concerning prolonged mechanical ventilation, risk factors were analyzed for all patients until Day 14. Currently, we can only speculate on a possible important time component of the effect of corticosteroids on the neuromuscular system to explain the beneficial effect on CIP/ CIM on the one hand, and the detrimental effect on prolonged mechanical ventilation on the other hand. Further studies are needed to confirm these results and to clarify possible underlying mechanisms.
Finally, other risk factors identified for prolonged mechanical ventilation were days of treatment with norepinephrine and bacteremia, which are associated with severity of illness. Exclusively receiving parenteral nutrition paradoxically appeared to be protective for prolonged mechanical ventilation. We think this is due to a selection bias, because these patients had a significantly shorter ICU stay.
Limitations
This study has some limitations. First, this study could not be blinded for obvious reasons. To minimize the bias, however, clear guidelines were used for sedation, mechanical ventilation, weaning, and patient discharge. Moreover, this is an analysis of the subgroup of patients in a randomized controlled trial who stayed in the ICU for at least 7 days. Because we did not collect ENMGs from patients who died or were discharged within the first week in the ICU, we could not perform an analysis on the total intention-to-treat population. By selecting the patients who were in the ICU for at least 1 week, we did select the more severely ill patients, who were often treated with corticosteroids, vasopressors, neuromuscular blocking agents, and renal replacement therapy. Hence, the high incidence of CIP/CIM we observed in the conventional group and the reduction by IIT may not necessarily apply to less sick patients who are in the ICU for less than 1 week. Moreover, the percentage of kilocalories administered by enteral route at 1 week was limited (22) , despite the use of a formal feeding protocol. Others have also noticed a major difference between the goals of nutrition and the actual amount administered, due to gastrointestinal complications (37, 38) or procedures (39) . It is unlikely, however, that this feeding aspect played a critical role because patients with CIP/CIM received equal amounts of parenteral feeding. Moreover, although a possible impact of parenteral feeding on CIP/CIM has been postulated, no study has shown a causal relationship between the administration of enteral or parenteral feeding and the development of CIP/CIM (8) , and neither have we. Another limitation of the study is that we did not perform follow-up ENMG evaluation of the patients who were discharged from the ICU, which could have rendered information on the duration of and recovery from CIP/CIM.
Finally, IIT currently has only been proven to have beneficial effects in two large randomized controlled trials at our center. Results of two subsequent studies, which were ended prematurely due to difficulties in safely achieving blood glucose control, have not been published in peer-reviewed journals. Also, IIT can be complicated by hypoglycemia. In our studies, hypoglycemia did not cause early deaths, only minor immediate and transient morbidity in a minority of patients, and no late neurologic sequelae among hospital survivors (40) . Nevertheless, prevention and early detection of hypoglycemia need to be a major concern when implementing this therapy.
We conclude that IIT is the only therapy that has been proven to actually decrease the incidence of CIP/CIM, and the incidence of prolonged mechanical ventilation, not only in a surgical population but also in a medical ICU population in which the incidence of other known risk factors for CIP/CIM is much higher. Further studies are needed to fully understand the biological mechanisms underlying this finding, and multicenter trials are needed to confirm these results.
